Healthcare & Life Sciences
RxATP helps drug and medical device registrants maintain accurate, audit-ready regulatory data — so agencies can always reach you when it matters.
Take the Industry Poll1 in 4 registrants had data on file that made them impossible to reach
A recent review of 298 U.S. drug and medical device distributor regulatory registrations found that 24.2% of registered contacts were effectively unreachable due to bounced emails, unmonitored forwarding, or typographical errors entered at registration. Inaccurate contact data is not an administrative oversight — it is a compliance violation that can result in fines, license suspension, or revocation.
47
Bounced — Address No Longer Exists
20
Forwarded — No One Monitoring Inbox
5
Typo Entered at Registration
Periodic reviews of state and federal registration data to identify gaps before regulators do.
Detect bounced contacts, unmonitored inboxes, and data entry errors that create exposure.
Understand how your compliance practices compare to peers across the industry.
Share how your organization handles regulatory contact data and see real-time results from compliance professionals across the industry.
Participate in the Poll